Last reviewed 2026-04-19 · How we verify

Drug: [18F]florbetaben

Sinotau Pharmaceutical Group · Phase 1 active Small molecule

Drug: [18F]florbetaben is a Small molecule drug developed by Sinotau Pharmaceutical Group. It is currently in Phase 1 development.

At a glance

Generic name	Drug: [18F]florbetaben
Sponsor	Sinotau Pharmaceutical Group
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Drug: [18F]florbetaben CI brief — competitive landscape report
Drug: [18F]florbetaben updates RSS · CI watch RSS
Sinotau Pharmaceutical Group portfolio CI

Frequently asked questions about Drug: [18F]florbetaben

What is Drug: [18F]florbetaben?

Drug: [18F]florbetaben is a Small molecule drug developed by Sinotau Pharmaceutical Group.

Who makes Drug: [18F]florbetaben?

Drug: [18F]florbetaben is developed by Sinotau Pharmaceutical Group (see full Sinotau Pharmaceutical Group pipeline at /company/sinotau-pharmaceutical-group).

What development phase is Drug: [18F]florbetaben in?

Drug: [18F]florbetaben is in Phase 1.

Manufacturer: Sinotau Pharmaceutical Group — full pipeline
Compare: Drug: [18F]florbetaben vs similar drugs
Pricing: Drug: [18F]florbetaben cost, discount & access